ACW ASX News

11 August 2024

ACW XanaCIDD phase 2a trial topline results

Actinogen's Xanamem shows significant benefits for depression in phase 2a trial.

Actinogen Medical Xanamem Clinical Trials Depression Treatment Stock Market News

Posted on: 11/08/2024

Read More

21 July 2024

ACW June 2024 quarterly activity report & Appendix 4C

Actinogen Medical releases promising trial results and financial updates.

Actinogen Medical Clinical Trials Alzheimer's Disease Stock Market News Biotechnology

Posted on: 21/07/2024

Read More